Midostaurin Plus Daunorubicin or Idarubicin for Young and Older Adults with FLT3-mutated AML: a Phase 3b Trial.
Blood Advances(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined